These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9072007)

  • 41. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
    Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
    Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma.
    Tseleni-Balafouta S; Gakiopoulou H; Fanourakis G; Voutsinas G; Balafoutas D; Patsouris E
    Exp Mol Pathol; 2006 Apr; 80(2):177-82. PubMed ID: 16259977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of parathyroid hormone-related peptide in human thyroid tumours.
    Nakashima M; Ohtsuru A; Luo WT; Nakayama T; Enomoto H; Usa T; Kiriyama T; Ito M; Nagataki S; Yamashita S
    J Pathol; 1995 Feb; 175(2):227-36. PubMed ID: 7738719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
    Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
    Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.
    Rossi ED; Raffaelli M; Mule' A; Miraglia A; Lombardi CP; Vecchio FM; Fadda G
    Histopathology; 2006 Jun; 48(7):795-800. PubMed ID: 16722927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia.
    Coli A; Bigotti G; Zucchetti F; Negro F; Massi G
    Histopathology; 2002 Jan; 40(1):80-7. PubMed ID: 11903601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laminin immunodetection in tumorous and nontumorous disorders of human thyroid.
    Charpin C; Kopp F; Pourreau-Schneider N; Lissitzky JC; Lavaut MN; Martin PM; Toga M
    Bull Cancer; 1985; 72(1):6-15. PubMed ID: 3886045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions.
    Herrmann ME; LiVolsi VA; Pasha TL; Roberts SA; Wojcik EM; Baloch ZW
    Arch Pathol Lab Med; 2002 Jun; 126(6):710-3. PubMed ID: 12033961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical expression of CXCR4 in thyroid carcinomas and thyroid benign lesions.
    He X; Wei Q; Zhang X; Xiao J; Jin X; Zhu Y; Cui B; Ning G
    Pathol Res Pract; 2010 Oct; 206(10):712-5. PubMed ID: 20646838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.
    Ermak G; Gerasimov G; Troshina K; Jennings T; Robinson L; Ross JS; Figge J
    Cancer Res; 1995 Oct; 55(20):4594-8. PubMed ID: 7553635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lectin histochemistry of papillary and follicular carcinoma of the thyroid gland.
    Sobrinho-Simões M; Damjanov I
    Arch Pathol Lab Med; 1986 Aug; 110(8):722-9. PubMed ID: 3089192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The expression of galectin-3 in nodular thyroid goitre].
    Chen WJ; Yu MH; Xu Y; Shen J
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):452-5. PubMed ID: 16831319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of lectin binding in benign and malignant thyroid nodules.
    Sasano H; Rojas M; Silverberg SG
    Arch Pathol Lab Med; 1989 Feb; 113(2):186-9. PubMed ID: 2916907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of alpha-amylase isozymes in human thyroid tissues.
    Doi S; Tomita N; Higasiyama M; Yokouchi H; Horii A; Yasuda T; Kobayashi T; Takai S; Ogawa M; Mori T
    Cancer Res; 1991 Jul; 51(13):3544-9. PubMed ID: 2054791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
    Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
    Samija I; Mateša N; Lukač J; Kusić Z
    Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical demonstration of thyroglobulin in thyroid pathology.
    Stefăneanu L; Simionescu L; Aman E; Taşcă C
    Endocrinologie; 1984; 22(1):55-9. PubMed ID: 6369503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential expression of S100C in thyroid lesions.
    Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
    Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms.
    Matesa-Anić D; Moslavac S; Matesa N; Cupić H; Kusić Z
    Acta Clin Croat; 2012 Jun; 51(2):237-41. PubMed ID: 23115948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.